ISB News

An Evening to Remember

carole

About 20 years ago, Carole Ellison attended a lecture by Dr. Lee Hood shortly after he had arrived at the University of Washington to start the Department of Molecular Biotechnology. She was impressed by his vision for the future of science and healthcare and vowed to meet him one day. This wish and her lifelong interest in science and human health led her to ISB.
This summer, Carole finally was able to meet Lee. She agreed to host a parlor meeting at her beautiful waterfront home in Kirkland for ISB friends, donors and supporters. The featured speaker was Dr. Ilya Shmulevich, professor at ISB, who presented a talk on “Deciphering the Complexity of Cancer.” (If you haven’t read the ISB Science Report inside this issue of Molecular Me, be sure to take a look. It discusses some of the cancer research that the Shmulevich group conducts.) After the presentation, the audience of about 50 guests engaged in a lively question-and-answer session with Ilya and Lee who worked in seamless tandem, drawing people into the research and mission of ISB.

The surprise of the evening was when Ilya stepped up to the baby grand piano and treated guests to a virtuosic performance that included Bach and Ginastera pieces. The evening was a perfect intersection of science, art and hospitality. Many thanks to Carole for her generosity.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.